| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Judith Clements | Q17523861 |
| Edward L. Giovannucci | Q20740896 | ||
| Atsushi Takahashi | Q59542748 | ||
| Esther M. John | Q59752419 | ||
| Sune G. Nielsen | Q59763235 | ||
| Douglas F. Easton | Q59812154 | ||
| Michelle Guy | Q59832092 | ||
| Jyotsna Batra | Q60550506 | ||
| Barbara Nemesure | Q60608201 | ||
| David J. Hunter | Q21066148 | ||
| Rosalind Eeles | Q24640445 | ||
| Stephen Chanock | Q27662321 | ||
| Demetrius Albanes | Q28321446 | ||
| Elio Riboli | Q28356166 | ||
| Kay-Tee Khaw | Q28356290 | ||
| Gianluca Severi | Q28360445 | ||
| Paul D P Pharoah | Q61822938 | ||
| Alan W Partin | Q62089936 | ||
| Suzanne Kolb | Q62592906 | ||
| Afshan Siddiq | Q63838079 | ||
| Lorelei A. Mucci | Q63964838 | ||
| Fredrik Wiklund | Q63967200 | ||
| Fredrick Schumacher | Q64183024 | ||
| Jianfeng Xu | Q67190177 | ||
| Daniel J. Schaid | Q67221693 | ||
| W. Ryan Diver | Q67470776 | ||
| Wei Zheng | Q67482021 | ||
| Freddie Hamdy | Q67482650 | ||
| Christopher A. Haiman | Q73606228 | ||
| Brian E. Henderson | Q73660621 | ||
| Sara Lindstroem | Q77022171 | ||
| Peter Kraft | Q77526208 | ||
| Christa Stegmaier | Q78334823 | ||
| Meir J. Stampfer | Q80164992 | ||
| Stephen N Thibodeau | Q84487521 | ||
| Sara Benlloch | Q84488170 | ||
| Radka Kaneva | Q84488364 | ||
| Federico Canzian | Q28360459 | ||
| Loic Le Marchand | Q28360612 | ||
| Jarmo Virtamo | Q28360660 | ||
| Henrik Grönberg | Q28466382 | ||
| Amy Hutchinson | Q28484160 | ||
| Hermann Brenner | Q28958315 | ||
| Graham Giles | Q30524411 | ||
| Kenneth Muir | Q42439735 | ||
| Malgorzata Tymrakiewicz | Q42575845 | ||
| Zsofia Kote-Jarai | Q42576837 | ||
| Daniel Leongamornlert | Q42576922 | ||
| Lisa Cannon-Albright | Q42577914 | ||
| Johanna Schleutker | Q42590313 | ||
| Jenny L Donovan | Q58658676 | ||
| Anssi Auvinen | Q47337660 | ||
| Tapio Visakorpi | Q49957442 | ||
| Charles S Chung | Q55089374 | ||
| Nora Pashayan | Q55174850 | ||
| Melissa C. Southey | Q55446228 | ||
| Hui-Yi Lin | Q56204883 | ||
| Dennis Hazelett | Q56855950 | ||
| Edward Saunders | Q56953094 | ||
| Tokhir Dadaev | Q56953141 | ||
| Shannon K McDonnell | Q56953402 | ||
| Ali Amin Al Olama | Q57565560 | ||
| Martin Andreas Røder | Q57573119 | ||
| Rick Kittles | Q57899085 | ||
| Agnieszka Michael | Q58212792 | ||
| Lisa B Signorello | Q114292647 | ||
| Richard B Biritwum | Q114300424 | ||
| Hardev Pandha | Q114312898 | ||
| PRACTICAL consortium | Q114312899 | ||
| Kathryn L Penney | Q114337746 | ||
| Phyllis J Goodman | Q114341310 | ||
| Sara S Strom | Q114341311 | ||
| Christine Neslund-Dudas | Q114341313 | ||
| Tiina Wahlfors | Q114367563 | ||
| Dominika Wokolorczyk | Q114367571 | ||
| Antje E Rinckleb | Q114367573 | ||
| Vanio Mitev | Q114367577 | ||
| Manuel Luedeke | Q114367586 | ||
| Sofia Maia | Q114367588 | ||
| Koveela Govindasami | Q114367593 | ||
| Laurie Burrows | Q114374083 | ||
| S Lilly Zheng | Q114387461 | ||
| Curtis A Pettaway | Q114407607 | ||
| Anselm J M Hennis | Q114409992 | ||
| M. Cristina Leske | Q114409993 | ||
| Kristin A Rand | Q114410837 | ||
| Wojciech Kluźniak | Q114456220 | ||
| Peggy Wan | Q114515548 | ||
| Merideth Yeager | Q114718048 | ||
| Ann Truelove | Q114718049 | ||
| Shelley Niwa | Q114718050 | ||
| Breast and Prostate Cancer Cohort Consortium (BPC3) | Q117271562 | ||
| Robert N. Hoover | Q118558329 | ||
| Daniel Stram | Q85936408 | ||
| Ruth Travis | Q86575888 | ||
| Lucy Xia | Q87101340 | ||
| Evelyn Yuxin Tay | Q87769679 | ||
| Benjamin A Rybicki | Q87885745 | ||
| Victoria L. Stevens | Q87885746 | ||
| Ann W Hsing | Q88329707 | ||
| Stephanie J. Weinstein | Q88595407 | ||
| Zhaoming Wang | Q89154327 | ||
| William B Isaacs | Q89161930 | ||
| Anand Chokkalingam | Q89232413 | ||
| Janet L Stanford | Q89339861 | ||
| Hidewaki Nakagawa | Q89402817 | ||
| Thomas A Sellers | Q89445791 | ||
| Kathleen Herkommer | Q90251754 | ||
| Susan M Gapstur | Q90864325 | ||
| Jonathan P Tyrer | Q91084019 | ||
| Teuvo L Tammela | Q91153452 | ||
| William J. Blot | Q91272971 | ||
| Adam B Murphy | Q91394215 | ||
| Mahbubl Ahmed | Q91496971 | ||
| Tim Keys | Q92040029 | ||
| Loreall Pooler | Q92481337 | ||
| Lisa Pei Chu | Q92482254 | ||
| David V Conti | Q93010760 | ||
| Yuan Yi Constance Chen | Q95950974 | ||
| Maren Weischer | Q96185909 | ||
| John D Carpten | Q96685876 | ||
| Matthew L Freedman | Q97587319 | ||
| Gerhard A. Coetzee | Q99609967 | ||
| Adam S Kibel | Q101212255 | ||
| Yao Tettey | Q106391645 | ||
| Sonja Berndt | Q109521956 | ||
| Elizabeth M Gillanders | Q114128092 | ||
| Laurence N Kolonel | Q114130594 | ||
| Cezary Cybulski | Q42590472 | ||
| Mitchell Machiela | Q42702781 | ||
| David E. Neal | Q42941105 | ||
| Børge G. Nordestgaard | Q43530123 | ||
| Amanda Spurdle | Q45904058 | ||
| Aida Karina Dieffenbach | Q37075433 | ||
| Chavdar Slavov | Q38641780 | ||
| Andrzej M. Kierzek | Q41117993 | ||
| Markus Aly | Q41584386 | ||
| Manuel R. Teixeira | Q41584388 | ||
| Michiaki Kubo | Q42316443 | ||
| P2093 | author name string | Kai Yu | |
| Sue A Ingles | |||
| Jing Ma | |||
| Ying Han | |||
| John S Witte | |||
| Christiane Maier | |||
| Jong Park | |||
| Qiyuan Li | |||
| Eric A Klein | |||
| Graham Casey | |||
| Xin Sheng | |||
| Peter Iversen | |||
| Andrew A Adjei | |||
| Edward D Yeboah | |||
| Chee Goh | |||
| Michael B Cook | |||
| Suh-Yuh Wu | |||
| Karen Park | |||
| Beatrice Knudsen | |||
| Paula Paulo | |||
| Sarah Holt | |||
| Peter Klarskov | |||
| Katri A Leinonen | |||
| Alex Stram | |||
| Antonio Hurtado Coll | |||
| COGS (Collaborative Oncological Gene-environment Study) Consortium | |||
| Daniella Seminara | |||
| GAME-ON/ELLIPSE Consortium | |||
| Sara Jugurnauth-Little | |||
| Yao, T. | |||
| P2860 | cites work | A flexible and accurate genotype imputation method for the next generation of genome-wide association studies | Q21129496 |
| The accessible chromatin landscape of the human genome | Q24595581 | ||
| New common variants affecting susceptibility to basal cell carcinoma | Q24615109 | ||
| CAS proteins in normal and pathological cell growth control | Q24630247 | ||
| Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility | Q24630647 | ||
| Summaries of Affymetrix GeneChip probe level data | Q27860888 | ||
| Exploration, normalization, and summaries of high density oligonucleotide array probe level data | Q27861098 | ||
| Multiple newly identified loci associated with prostate cancer susceptibility | Q28268180 | ||
| Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP | Q80180814 | ||
| miRcode: a map of putative microRNA target sites in the long non-coding transcriptome | Q28914775 | ||
| Genome-wide association study identifies new prostate cancer susceptibility loci | Q28924380 | ||
| Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population | Q28943484 | ||
| Multiple loci identified in a genome-wide association study of prostate cancer | Q28943507 | ||
| Large-scale genotyping identifies 41 new loci associated with breast cancer risk | Q29416989 | ||
| Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls | Q29417049 | ||
| Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array | Q29417155 | ||
| METAL: fast and efficient meta-analysis of genomewide association scans | Q29547217 | ||
| Genome-wide association study identifies five susceptibility loci for glioma | Q29614921 | ||
| Serine protease mechanism and specificity | Q29616734 | ||
| Final report on the aspirin component of the ongoing Physicians' Health Study | Q29619461 | ||
| ProbABEL package for genome-wide association analysis of imputed data | Q33541240 | ||
| Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans | Q33921139 | ||
| GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus. | Q34013791 | ||
| Germline p16 mutations in familial melanoma | Q34059915 | ||
| Genome-wide association study identifies five new breast cancer susceptibility loci | Q34114293 | ||
| TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion | Q57693484 | ||
| Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA | Q34185076 | ||
| Integrative eQTL-based analyses reveal the biology of breast cancer risk loci | Q34194768 | ||
| FunciSNP: an R/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs | Q34298932 | ||
| Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi | Q34831505 | ||
| Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. | Q35009643 | ||
| Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells | Q35598835 | ||
| Integration of Regulatory Networks by NKX3-1 Promotes Androgen-Dependent Prostate Cancer Survival | Q35665662 | ||
| Estimation of effect size distribution from genome-wide association studies and implications for future discoveries | Q36191121 | ||
| Evaluating genetic risk for prostate cancer among Japanese and Latinos | Q36388749 | ||
| Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility | Q36582802 | ||
| The discovery and application of gene fusions in prostate cancer | Q37142194 | ||
| Sequence variants at 22q13 are associated with prostate cancer risk | Q37250824 | ||
| Comprehensive functional annotation of 77 prostate cancer risk loci | Q37533894 | ||
| A genome-wide association study of prostate cancer in West African men | Q37705188 | ||
| The genetic epidemiology of prostate cancer and its clinical implications | Q38168060 | ||
| Fluorescence and chromogenic in situ hybridization to detect genetic aberrations in formalin-fixed paraffin embedded material, including tissue microarrays | Q38427746 | ||
| The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man. | Q39222325 | ||
| Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors | Q39283917 | ||
| Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese | Q39389957 | ||
| Overexpression of myosin VI in prostate cancer cells enhances PSA and VEGF secretion, but has no effect on endocytosis | Q39783600 | ||
| Myosin VI is a modulator of androgen-dependent gene expression. | Q39794012 | ||
| TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis. | Q39976204 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| susceptibility locus | Q62091149 | ||
| P304 | page(s) | 1103-1109 | |
| P577 | publication date | 2014-01-01 | |
| 2014-09-14 | |||
| P1433 | published in | Nature Genetics | Q976454 |
| Nature | Q180445 | ||
| P1476 | title | A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer | |
| P478 | volume | 46 |
| Q90339863 | 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population |
| Q38744293 | 4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus |
| Q35327105 | A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer |
| Q46008772 | A Prostate Cancer Risk Element Functions as a Repressive Loop that Regulates HOXA13. |
| Q26752649 | A comparison of genetic risk score with family history for estimating prostate cancer risk |
| Q37225298 | A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population |
| Q92937384 | A genome-wide association study of prostate cancer in Latinos |
| Q90084057 | A high-resolution 3D epigenomic map reveals insights into the creation of the prostate cancer transcriptome |
| Q47145331 | A microsatellite repeat in PCA3 long non-coding RNA is associated with prostate cancer risk and aggressiveness |
| Q38725930 | A multiparametric approach to improve upon existing prostate cancer screening and biopsy recommendations |
| Q48515655 | A review of prostate cancer genome wide association studies (GWAS). |
| Q38636792 | ADNP: in search for molecular mechanisms and innovative therapeutic strategies for frontotemporal degeneration |
| Q33883502 | Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial |
| Q55229709 | Admixture Mapping Links RACGAP1 Regulation to Prostate Cancer in African Americans. |
| Q51807661 | African-American Prostate Cancer Disparities |
| Q56333953 | Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age |
| Q37417691 | Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study |
| Q62491978 | An AR-ERG transcriptional signature defined by long-range chromatin interactomes in prostate cancer cells |
| Q64100346 | An Overview of the Polymorphisms of Circadian Genes Associated With Endocrine Cancer |
| Q92354916 | An epigenome-wide association study of sex-specific chronological ageing |
| Q36663319 | An examination of clinical differences between carriers and non-carriers of chromosome 8q24 risk alleles in a New Zealand Caucasian population with prostate cancer. |
| Q91362482 | An exome-wide rare variant analysis of Korean men identifies three novel genes predisposing to prostate cancer |
| Q64068156 | An expanded variant list and assembly annotation identifies multiple novel coding and noncoding genes for prostate cancer risk using a normal prostate tissue eQTL data set |
| Q98237725 | An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk |
| Q46324231 | Analysis of Tumor Biology to Advance Cancer Health Disparity Research. |
| Q24170413 | Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types |
| Q37118791 | Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels |
| Q58583792 | Association Analysis of a Microsatellite Repeat in the Gene With Prostate Cancer Risk, Aggressiveness and Survival |
| Q30253080 | Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study |
| Q57305944 | Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q36918116 | Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes |
| Q93271728 | Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer |
| Q91902230 | Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanisms |
| Q36100579 | Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases |
| Q36792641 | Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation |
| Q62583664 | Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus |
| Q37474443 | Biomarkers for prostate cancer: present challenges and future opportunities |
| Q30241244 | CCAFU french national guidelines 2016-2018 on prostate cancer |
| Q57294396 | CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops |
| Q27317433 | Calcium can mobilize and activate myosin-VI |
| Q91211233 | Cancer genetics, precision prevention and a call to action |
| Q49888054 | Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies. |
| Q57796257 | Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study |
| Q45071502 | Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study |
| Q47142753 | Cis-SNPs Set Testing and PrediXcan Analysis for Gene Expression Data using Linear Mixed Models. |
| Q41201216 | Clinical Consultation Guide: How to Optimize the Use of Prostate-specific Antigen in the Current Era. |
| Q37700218 | Clinical and histopathological characteristics of patients with prostate cancer in the BioBank Japan project |
| Q26746219 | Clinical validity and utility of genetic risk scores in prostate cancer |
| Q40149181 | Cohort Profile: The Melbourne Collaborative Cohort Study (Health 2020). |
| Q28397098 | Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors |
| Q37306979 | Comparing performance of modern genotype imputation methods in different ethnicities |
| Q28388475 | Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations |
| Q92510114 | Cross-Cancer Pleiotropic Associations with Lung Cancer Risk in African Americans |
| Q92881524 | Cross-population analysis for functional characterization of type II diabetes variants |
| Q52426413 | Crucial role of noncoding RNA in driving prostate cancer development and progression |
| Q91669790 | Current progress and questions in germline genetics of prostate cancer |
| Q90742977 | DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs |
| Q47097550 | Deletion of tumor suppressors adenomatous polyposis coli and Smad4 in murine luminal epithelial cells causes invasive prostate cancer and loss of androgen receptor expression |
| Q89161935 | Differences in inherited risk among relatives of hereditary prostate cancer patients using genetic risk score |
| Q36918154 | Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus |
| Q60472142 | Discovery of common and rare genetic risk variants for colorectal cancer |
| Q28084601 | Do Health Professionals Need Additional Competencies for Stratified Cancer Prevention Based on Genetic Risk Profiling? |
| Q26801418 | Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma |
| Q38402430 | Estimating Heritability of Prostate Cancer-Specific Survival Using Population-Based Registers |
| Q36144811 | Estimation of heritability for nine common cancers using data from genome-wide association studies in Chinese population |
| Q97533745 | Ethnic variation in prostate cancer detection: a feasibility study for use of the Stockholm3 test in a multiethnic U.S. cohort |
| Q38734618 | Exome-based genome-wide association study and risk assessment using genetic risk score to prostate cancer in the Korean population |
| Q64279946 | Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients |
| Q40950245 | Exploration of the molecular mechanism of prostate cancer based on mRNA and miRNA expression profiles |
| Q33874409 | Familial Risk and Heritability of Cancer Among Twins in Nordic Countries |
| Q88875064 | Familial prostate cancer |
| Q55311842 | Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. |
| Q88911128 | From genome-wide associations to candidate causal variants by statistical fine-mapping |
| Q35784256 | Functional annotation of HOT regions in the human genome: implications for human disease and cancer. |
| Q90731225 | Functional deficiency of DNA repair gene EXO5 results in androgen-induced genomic instability and prostate tumorigenesis |
| Q37636741 | Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk |
| Q38830853 | GNL3 and SKA3 are novel prostate cancer metastasis susceptibility genes |
| Q35952814 | Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array |
| Q38788399 | Gene regulatory mechanisms underpinning prostate cancer susceptibility |
| Q38738916 | GeneImp: Fast Imputation to Large Reference Panels Using Genotype Likelihoods from Ultralow Coverage Sequencing. |
| Q38883998 | Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci. |
| Q92963829 | Genetic associations of breast and prostate cancer are enriched for regulatory elements identified in disease-related tissues |
| Q47404155 | Genetic factors influencing prostate cancer risk in Norwegian men. |
| Q37724216 | Genetic pleiotropy between age-related macular degeneration and 16 complex diseases and traits |
| Q39035687 | Genetic predisposition to prostate cancer. |
| Q48197879 | Genetic risk of prostate cancer in ugandan men. |
| Q47171954 | Genetic risk score to predict biochemical recurrence after radical prostatectomy in prostate cancer: prospective cohort study |
| Q38873932 | Genetic variants associated with mosaic Y chromosome loss highlight cell cycle genes and overlap with cancer susceptibility |
| Q41017874 | Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma |
| Q40625323 | Genetic variants of the Wnt signaling pathway as predictors of aggressive disease and reclassification in men with early stage prostate cancer on active surveillance. |
| Q85345069 | Genetics of celiac disease |
| Q38478054 | Genetics of diabetic nephropathy: a long road of discovery. |
| Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
| Q54247816 | Genome-wide Association Study (GWAS) of Germline Copy Number Variations (CNVs) Reveal Genetic Risks of Prostate Cancer in Chinese population |
| Q57139643 | Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival |
| Q40718874 | Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21. |
| Q47703675 | Genome-wide association studies in glioma. |
| Q38668307 | Genome-wide association studies of cancer in diverse populations |
| Q47900293 | Genome-wide association studies of cancer: current insights and future perspectives |
| Q37191879 | Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma |
| Q24263464 | Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma |
| Q38970751 | Genome-wide association study of prostate cancer-specific survival |
| Q40363836 | Genome-wide two-locus interaction analysis identifies multiple epistatic SNP pairs that confer risk of prostate cancer: A cross-population study. |
| Q51003983 | Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death |
| Q38855675 | Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer |
| Q36471474 | Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer |
| Q36152825 | Germline Variants of Prostate Cancer in Japanese Families. |
| Q37474516 | Germline genetic profiling in prostate cancer: latest developments and potential clinical applications. |
| Q91496974 | Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT |
| Q64966871 | Haplotypes spanning centromeric regions reveal persistence of large blocks of archaic DNA. |
| Q38647896 | Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium |
| Q40704483 | Heritability of prostate cancer: a tale of rare variants and common single nucleotide polymorphisms. |
| Q90091185 | Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants |
| Q42090895 | Identifying aggressive prostate cancer foci using a DNA methylation classifier |
| Q35700710 | Impact of genetic similarity on imputation accuracy |
| Q47151248 | Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours. |
| Q44213510 | Improvement in prediction of prostate cancer prognosis with somatic mutational signatures |
| Q92683302 | Induction of apoptosis and modulation of homologous recombination DNA repair pathway in prostate cancer cells by the combination of AZD2461 and valproic acid |
| Q38701501 | Inherited determinants of early recurrent somatic mutations in prostate cancer. |
| Q47158582 | Integration of Genome Scale Metabolic Networks and Gene Regulation of Metabolic Enzymes With Physiologically Based Pharmacokinetics |
| Q31159857 | Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes. |
| Q36065460 | Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions |
| Q89717694 | Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry |
| Q38842066 | Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3. |
| Q36003630 | Invited commentary: screening and the elusive etiology of prostate cancer |
| Q28072585 | Is birthweight associated with total and aggressive/lethal prostate cancer risks? A systematic review and meta-analysis |
| Q48336884 | Is the Genetic Background of Co-Stimulatory CD28/CTLA-4 Pathway the Risk Factor for Prostate Cancer? |
| Q57307160 | Known susceptibility SNPs for sporadic prostate cancer show a similar association with “hereditary” prostate cancer |
| Q36250030 | Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer |
| Q57030056 | Large-scale transcriptome-wide association study identifies new prostate cancer risk regions |
| Q34572467 | Leveraging population admixture to characterize the heritability of complex traits |
| Q93048458 | Liquid Biopsy in Oligometastatic Prostate Cancer-A Biologist's Point of View |
| Q30276350 | Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer. |
| Q93020377 | Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer |
| Q35957484 | Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study |
| Q38751776 | Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer. |
| Q50133991 | Molecular Biomarkers in the Clinical Management of Prostate Cancer |
| Q57112111 | Molecular Subtypes of Prostate Cancer |
| Q33677773 | Molecular classification of prostate adenocarcinoma by the integrated somatic mutation profiles and molecular network |
| Q38596777 | Multigene panels in prostate cancer risk assessment: a systematic review |
| Q35646703 | Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans |
| Q36633535 | Mutational Landscape of Aggressive Prostate Tumors in African American Men |
| Q47112493 | Network-directed cis-mediator analysis of normal prostate tissue expression profiles reveals downstream regulatory associations of prostate cancer susceptibility loci |
| Q40386684 | New insights into the genetics of primary open-angle glaucoma based on meta-analyses of intraocular pressure and optic disc characteristics |
| Q33618785 | Next generation mapping reveals novel large genomic rearrangements in prostate cancer |
| Q92129186 | Novel Poly(Adenosine Diphosphate-Ribose) Polymerase (PARP) Inhibitor, AZD2461, Down-Regulates VEGF and Induces Apoptosis in Prostate Cancer Cells |
| Q36907762 | Pan-cancer analyses of the nuclear receptor superfamily |
| Q37113160 | Personalized prostate cancer care: from screening to treatment |
| Q38879685 | Pleiotropy-robust Mendelian randomization |
| Q39524941 | Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium |
| Q37513339 | Population-based precision cancer screening: a symposium on evidence, epidemiology, and next steps |
| Q37113165 | Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer |
| Q89022026 | Pre-diagnostic Serum Metabolomic Profiling of Prostate Cancer Survival |
| Q36356727 | Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores |
| Q41584352 | Prediction of individual genetic risk to prostate cancer using a polygenic score |
| Q38919453 | Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness. |
| Q52566012 | Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities. |
| Q50175857 | Prostate Cancer Germline Variations and Implications for Screening and Treatment |
| Q40179631 | Prostate cancer incidence as an iceberg |
| Q89741561 | Prostate cancer risk SNP rs10993994 is a trans-eQTL for SNHG11 mediated through MSMB |
| Q33640983 | Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status |
| Q29030107 | Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study |
| Q85650444 | Prostate cancer: genetic risk analysis goes global |
| Q36469793 | Putative Prostate Cancer Risk SNP in an Androgen Receptor-Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in Androgen Receptor Target Sites |
| Q37158420 | Quantifying the utility of single nucleotide polymorphisms to guide colorectal cancer screening |
| Q42731004 | Rare Variation in TET2 Is Associated with Clinically Relevant Prostate Carcinoma in African Americans |
| Q57177774 | Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease |
| Q40137394 | Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial. |
| Q92153545 | Reconstitution reveals how myosin-VI self-organises to generate a dynamic mechanism of membrane sculpting |
| Q36295073 | Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC. |
| Q36146953 | Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context |
| Q35815958 | Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci |
| Q38382935 | SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patterns |
| Q38591731 | Single nucleotide polymorphisms in clinics: Fantasy or reality for cancer? |
| Q88568776 | Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival |
| Q40197058 | Spectrum of mitochondrial genomic variation and associated clinical presentation of prostate cancer in South African men. |
| Q38693601 | Sports genetics moving forward: lessons learned from medical research |
| Q99571190 | Survival outcomes in men with a positive family history of prostate cancer: a registry based study |
| Q38503798 | Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk-associated loci |
| Q92993050 | Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts |
| Q52725879 | The Epidemiology of Prostate Cancer |
| Q64999279 | The Human TET2 Gene Contains Three Distinct Promoter Regions With Differing Tissue and Developmental Specificities. |
| Q41537095 | The Mediterranean Diet Reduces the Risk and Mortality of the Prostate Cancer: A Narrative Review |
| Q34674332 | The Molecular Taxonomy of Primary Prostate Cancer |
| Q37578078 | The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers |
| Q38559825 | The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource |
| Q37349051 | The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited |
| Q38856899 | The contribution of rare variation to prostate cancer heritability |
| Q89594348 | The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial |
| Q38540636 | The genomic evolution of human prostate cancer. |
| Q88778863 | The personal and clinical utility of polygenic risk scores |
| Q92060499 | The prostate cancer risk variant rs55958994 regulates multiple gene expression through extreme long-range chromatin interaction to control tumor progression |
| Q39018270 | The psychological impact of undergoing genetic-risk profiling in men with a family history of prostate cancer |
| Q28383497 | Trans-ethnic genome-wide association studies: advantages and challenges of mapping in diverse populations |
| Q43051933 | Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry. |
| Q35575585 | Two susceptibility loci identified for prostate cancer aggressiveness |
| Q37583398 | Use of a Novel Nonparametric Version of DEPTH to Identify Genomic Regions Associated with Prostate Cancer Risk |
| Q49639446 | Validation of the novel susceptibility loci for prostate cancer in a Chinese population |
| Q36071737 | Vitamin D receptor and RXR in the post-genomic era. |
| Q38871819 | What's new in screening in 2015? |
| Q37686900 | Whole exome sequencing in 75 high-risk families with validation and replication in independent case-control studies identifies TANGO2, OR5H14, and CHAD as new prostate cancer susceptibility genes |
| Q36895709 | Whole-exome sequencing of over 4100 men of African ancestry and prostate cancer risk |
| Q28917124 | Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data |
| Q104517654 | [French ccAFU guidelines - update 2020-2022: prostate cancer] |
Search more.